Author | Evelyn Sansregret, MD


Docetaxel/Doxorubicin/Cyclophosphamide in the Treatment of Metastatic Breast Cancer

August 01, 1997

ByJean-marc A. Nabholtz, MD|Michael Smylie, MD|John R. Mackey, MD|Dick Au, MD|Evelyn Sansregret, MD|Daniel Noel, MD|Alexander H. Paterson, MD|Taher Al-tweigeri, MD|Fernad Delorme, MD|Allesandro Riva, MD

Preliminary results from phase I trials suggest that the use of docetaxel (Taxotere) and doxorubicin (Adriamycin) is a well tolerated and highly active combination regimen for